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treatments, n = 17), Clinical effectiveness were assessed
with the Hamilton Anxiety Scale (HAMA17) by treatment
before and after 2 weeks, 4 weeks.
Results: Beginning at treatment Week2, the score of
the HAMA decreased gradually in the experiment group,
however there was no signiﬁcant difference in the score of
the HAMA between the 2 groups (P> 0.05), and the score of
the HAMA decreased more signiﬁcantly in the experiment
group by treating weeks 4. The score of the HAMA in the
control group change was signiﬁcantly higher than seen in
the experiment group (P< 0.05).
Conclusions: Transmetil has precise effectiveness in the
treatment for those patients with with depressed emotion
and Chronic liver failure in hepatitis B.
Table. Comparison of HAMA scores between two groups before and after
treatment
Group Before After treatment
treatment Week 2 Week 4
Experimental (n = 25) 13.34±3.86 10.54±4.11* 8.04±2.52**
Control (n = 13) 12.85±4.13 11.27±5.23* 11.89±3.78*
Data are the mean±SE, n = 38.
*P > 0.05, **P < 0.05 compared with treatment before; *P > 0.05, **P < 0.05
compared with the control group respectively.
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Aim: Our aim was to assess the feasibility of Methacetin
breath tests in decreasing mortality during or after liver
resection, predict complications and liver failure after
the resection. To the best of our knowledge there is no
study that checks liver function using Methacetin by oral
administration (indeed there is one study that uses IV
administration).
Method: Methacetin C13 breath test was kindly donated
by Beijing Richen Science and Technology Co., Ltd. 10
empty breaths were collected before each measurement
and 75mg/80ml methacetin was orally administered. After
administration 9 breaths at 10, 20, 30, 40, 50, 60, 80,
100 and 120 minutes were collected in the bags provided
by the manufacturer. Breath test was performed on the
day before operation, post operation days 1 and 10.
Patients with projected resection of more than 20% of the
liver were included in the study. Additional parameters
like liver enzymes, Child-Pugh score, platelets, albumin,
CT volumetry were assessed. Total of 42 patients were
included in the study, out of which 5 were healthy controls.
23 patients canceled operation because of insufﬁcient
liver function. 14 patients participated until the last
measurement of day 10 at National Cancer Center of
Mongolia. Three parameters of the methacetin breath test:
methacetin concentration after 30 min of administration
CUM30, highest concentration of methacetin DOB peak, and
calculated liver function using the software provided by the
manufacturer were obtained after each measurement.
Result: 5 healthy controls had the mean DOB peak value of
29.056, CUM30 of 91.56 and liver function 114.
When 20% of the liver was resected Methacetin
concentration was decreased by 47.09% (DOB peak), 72.1%
(CUM30), 63.22% (calc. liver function); when 35% resected
45.33%, 73.35%, and 74.28%; when 40% cut: 39.04%, 99.3%,
99.3%; when 50% cut 67.38%, 81.97%, 75.2%; when 65%
cut: values were 37.51%, 54.27% and 42.97% respectively.
All patients were Child-Pugh A, and mean albumin was
3.8 g/dl and platelets were 229×109/L, ALT 179IU/L and AST
162IU/L respectively. In terms of predicting complications
we observed DOB peak has the most meaningful results with
5 out of 6 patients with post operative complications had a
value of <20, while 6 out of 7 patients without complications
had values >20.
Conclusion: 3 parameters of the methacetin breath test
(methacetin concentration after 30 min of administration
CUM30, highest concentration of methacetin DOB peak,
and calculated liver function using the software provided
by the manufacturer) were compared the amount of liver
cut away. The closest parameter to the amount of liver
resected was the highest concentration of methacetin DOB
peak, whereas CUM 30 and liver function did not match
the amount as that of DOB peak. We suggest the cut off
value of DOB peak at 20. This method is non-invasive,
non-toxic, direct method to assess liver function with high
predictive and dynamic range in regard to residual liver
function. The sensitivity of the methacetin test to predict
post-operative complications were 83%, and the speciﬁcity
stands at 85% with PPV (Positive Predictive Value) = 83%,
and NPV (Negative Predictive Value) = 85% respectively. The
most common post-operative complications we encountered
were ascitis and wound infections.
Liver cirrhosis
Control
(n = 5)
Non cirrhosis
(n = 8)
Child Pugh
(n = 5)
DOB peak 29.06 25.29 18.56
CUM 30 91.56 94.01 64.32
Liver function 114 104.79 77.71
Complications after surgery
Control
(n = 5)
Complication
(n = 7)
Non complication
(n = 6)
DOB peak 29.06 26.56 18.21
CUM 30 91.56 89.84 74.12
Liver function 114 106.87 79.79
PP-154 Effects of Alzet mini-osmotic pumps controlled
release of IGFBPrP1 on liver and lung in mice
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of Shanxi Medical University, China
Objectives: IGFBPrP1 was released at a continuous constant
dose by Alzet mini-osmotic pump which was implanted
subcutaneously of wild-type mice, Compare the effects
of IGFBPrP1 on liver and lung tissues and explore its
mechanism.
Methods: Mice were randomly divided into normal group,
sham-operated group and Operation group. We used
rmIGFBPrP1 which was released by capsule osmotic pump
to make the model. Sham-operated group was only treated
by control operation. HE and Picrosirius red staining were
used to evaluate pathomorphological changes and collagen
generation. The expression and distribution of IGFBPrP1,
Collagen-III, Smad3, p-Smad2/3 protein in mice hepatic and
lung tissues were tested by immunohistochemistry methods.
Apoptosis of hepatic cells was investigated by TUNEL.
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Results: Comparing with the control group and sham-
operated group, inﬂammation occurred and collagen
content increased, the expression of IGFBPrP1, Collagen
III, p-Smad2/3, Smad3 increased in liver tissue of Operation
group (P < 0.01). While the differences of those in lung
tissue were not signiﬁcant (P < 0.05). More TUNEL positive
cells were found in operative group than normal group and
sham-operated group (P < 0.01).
Conclusion: Exogenous IGFBPrP1 released at a continuous
constant dose may induce hepatic ﬁbrosis of mice. On the
same condition, the effect of IGFBPrP1 on mice lung tissue
was weaker than that on hepatic tissue and pulmonary
ﬁbrosis was not found. IGFBPrP1 maybe has a selectively
functions on mice tissue.
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Objectives: To investigate the effect of exogenous
recombinant mouse insulin-like growth factor binding
protein related protein 1 (rmIGFBPrP1) on both liver and
kidney tissue with mouse, explore the mechanism of
rmIGFBPrP1 on ﬁbrosis.
Methods: A total of 26 clean male wild-type C57BL/6 mice
were randomly divided into normal control group, sham-
operated group and model group. We used rmIGFBPrP1
which was released by capsule osmotic pump to make the
model. HE staining and Sirius red staining were observed to
investigate the pathological changes, deposition of collagen
ﬁbers of both liver and kidney of mice. The expression and
distribution of IGFBPrP1, Smad3, p-Smad2/3, III collagen
(Collagen III) of liver and kidney tissues were detected by
immunohistochemistry. Hepatocyte apoptosis was detected
by DUTP nick end labeling (TUNEL).
Results: Comparing with the control group and sham-
operated group, the content of collagen ﬁber increased,
expression of IGFBPrP1, Smad3, p-Smad2/3, Collagen III
increased (P < 0.01) in the liver of model group. Only
the expression of IGFBPrP1 in the kidney of model group
increased than the control group and sham-operated group
(P < 0.01), there is no difference on collagen ﬁbers content
and Other indicators expression (P > 0.05). TUNEL showed an
increase in ratio of apoptotic liver cells in model group than
the normal group and sham-operated group, the difference
was statistically signiﬁcant (P < 0.01).
Conclusion: Exogenous IGFBPrP1 can promote hepatocyte
apoptosis and liver ﬁbrosis, but have little effect on the
mice kidney. IGFBPrP1 maybe has the selectivity on inducing
organs and organization ﬁbrosis of mouse.
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Objectives: To investigate the inﬂuence of inhibiting
insulin-like growth factor binding protein related protein1
(IGFBPrP1) by chemically synthesized small interfering RNA
(siRNA) on apoptosis of HSC-T6 cells and to explore the
possible mechanism.
Methods: Divide the HSC-T6 cells into three groups as
following: normal control group, negative control group
and IGFBPrP1 siRNA transfection group. The IGFBPrP1 siRNA
was transfected into HSC-T6 cells. After transfecting with
different time, cell proliferation was measured by CCK-8
assay, cell apoptosis was detected by ﬂow cytometry with
AnnexinV/PI double staining, both p53 and bcl-2 protein
expressions were detected by immunocytochemistry.
Results: (24 h, 48 h, 72 h) after IGFBPrP1 siRNA transfection,
the rates of proliferation inhibition were (25%, 32%, 28%);
apoptotic rates of IGFBPrP1 siRNA transfection groups
were increased compared with the normal control group
and the negative control group, respectively, (P < 0.01).
Immunocytochemistry showed that the expression of p53
protein was signiﬁcantly increased and the expression of
bcl-2 protein was signiﬁcantly decreased compared with
the normal control group and the negative control group,
respectively, (P < 0.01).
Conclusion: IGFBPrP1 siRNA is able to inhibite the cell
proliferation signiﬁcantly and induce apoptosis of HSC-T6
cells effectively. Apoptosis of HSC-T6 cells induced by
IGFBPrP1 siRNA may be associated with up-regulation of
p53 expression and down-regulation of bcl-2 expression.
RNAi against IGFBPrP1 may provide a new strategy for the
treatment of liver ﬁbrosis.
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More and more efforts have been making in order
to trigger hepatocyte regeneration through autological
bone marrow stem cells in severe chronic liver disease
although the condition and mechanism of bone marrow
stem cell differentiation into hepatocyte remains blurred.
We report a case of compensated cirrhosis induced by
chronic hepatitis B. The patient accepted portal infusion of
autologous CD133+ mononuclear cells combined with portal
vein embolisation after granulocyt colohy-stimulatins factor
(G-CSF) mohilization, bone marrow stem cells collection
and selection.A mild ﬂare of serum bilirubin, alanine
aminotransferase, albumin, fetoproten and blood platelet
count were observed within two weeks after procedure.
The serum aspartate aminotransferase and white blood
cell count showed a temporary raise, then returned to
basis level rapidly. The most import observation is the
hepatic volumetry of segment concerned stem cells infusion
signiﬁcantly increased from 368ml to 468ml three months
later after therapy. No obvious reactions and comlications
were found in this patient. Intrahepatic infusion of bone
morrow stem cells seemed safe and associates with
enlarging hepatic functional remnant volume, a promising
approach to accelerate the repopulation of hepatocytes in
patient with cirrhosis.
PP-158 Steroid resistance: the main blockhouse in the
treatment of alcoholic hepatitis
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Alcoholic hepatitis (AH) is a necrotizing inﬂammatory lesion
of alcoholic liver injury with signiﬁcant short-term mortality.
The management of AH is challenging. Corticosteroids,
demonstrated anti-inﬂammatory and antiﬁbrotic effects,
are the most intensely studied and yet most hotly debated
treatment for AH. There are more than 17 controlled
trials and at least 13 meta-analyses about corticosteroids
treatment in AH in the past 40 years. Many of them are
poorly designed and varying in inclusion/exclusion criteria,
which make it hard to reach a consensus conclusion. To
resolve this confounding, researchers in both sides of the
controversy all made Cochrane review through combining
